Osteoclast-targeted treatment of mouse CaPO4-induced aneurysms (TNFα and CaPO4-dependent, RANKL-independent) with bisphosphonate was effective in inhibiting aneurysm formation and TRAP expression [18]. This evidence concerns the gene TRAF2 and aneurysm.